Note: supply of these mice from University College London will include one male and two females as a package. Only one package will be supplied for each approved request.
Pdgfb-CreER mice express tamoxifen inducible Cre-recombinase in endothelial cells of the microvasculature. They have been made by using a PAC containing the Pdgfb gene for transgenesis (random integration). The ORF of the Pdgfb gene was replaced with the coding sequence for the fusion protein iCreERT2 (iCre stands for improved Cre), followed by an IRES and the coding sequence for EGFP (See PMID: 18257043 for more details).
Placing an order on XIP
To license this product, please select the appropriate licence option on the right-hand side of this page. Terms can be previewed from the "Preview terms" link.
MTAs require agreement between all the parties involved in supplying and receiving a product. This cannot happen instantaneously but is a controlled process, managed through XIP and should not take longer no than 10 business days in ordinary circumstances.
To place an order, please locate the Sign-in or Register options on the top right side of this page. You can either sign in to your existing account or register for a new now. Please note that your account should be created using your academic/ institutional e-mail address.
For additional guidance on how to create an account and place an order, refer to the FAQs.
-
swap_vertical_circlelibrary_booksReferences (1)
- Fruttiger, Hodivala-Dilke, Chambon, Jadeja, Kostourou, Claxton (2008), Efficient, inducible Cre-recombinase activation in vascular endothelium, Genesis, 46(2), 74-80
-
swap_vertical_circlecloud_downloadSupporting documents (1)Pdgfb-CreER mice protocol.docPdgfb-CreER mice protocol.docPdgfb-CreER mice protocol.doc (479 KB)DOWNLOADAdditional files may be available once you've completed the transaction for this product. If you've already done so, please log into your account and visit My account / Downloads section to view them.